SEARCH

SEARCH BY CITATION

Additional Supporting Information may be found in the online version of this article.

FilenameFormatSizeDescription
ijc28150-sup-0001-suppinfo.doc167K

S figure Period specific hazard ratios (breast specific and relapse free) for the time dependent breast cancer sub-types

S figure Period specific hazard ratios (all-cause, breast specific and relapse free) for the time dependent breast cancer sub-types

S figure Period specific hazard ratios (all cause, breast specific and relapse free) for the time dependent breast cancer sub-types for HER2 vs Luminal 1 (complete case analysis versus multiple imputation)

S figure Period specific hazard ratios (all-cause, breast specific and relapse free) for the time dependent breast cancer sub-types for TNP vs Luminal 1 (Complete case analysis versus multiple imputation)

S figure Period specific hazard ratios (breast specific and relapse free) for the time dependent breast cancer sub-types for Luminal 2 vs L1 negative (Complete case analysis versus multiple imputation)

S figure Period specific hazard ratios (breast specific and relapse free) for the time dependent breast cancer sub-types for Luminal 2 vs Luminal 1 positive (Complete case analysis versus multiple imputation)

S figure Hazard ratios and CIs of E-CMF vs CMF for breast cancer sub-types (Complete case analysis (left) versus multiple imputation (right))

S figure Kaplan-Meier cumulative survival (breast cancer specific mortality) in different sub-groups by treatment.

S table Antibodies used and the scoring schemes.

S table Adjusted hazard ratios and CIs for breast cancer sub-types

S table Hazard ratios and CIs for breast cancer sub-types (all cause, breast specific, relapse free) using multiple imputation (MI)

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.